This study was designed to clarify the cardioprotective effects of various class I antiarrhythmic drugs, i .e., aprindine, disopyramide, flecainide, lidocaine, mexiletine, pentisomide and propafenone, on the ischemic heart . Sixty-one adult mongrel dogs were classified into eight groups according to premedication 1) control group, physiologic saline solution was administered intravenously 25 min before left anterior descending coronary artery ligation ; 2) aprindine group, 3 mg/kg body weight of aprindine intravenously ; 3) disopyramide group, 2 mg/kg of disopyramide intravenously ; 4) fiecainide group, 2 mg/kg of flecainide intravenously followed by drip infusion of 100 µg/kg per min ; 5) lidocaine group, 2 mg/kg of lidocaine intravenously followed by drip infusion of 100 µg/kg per min ; 6) mexiletine group, 3 mg/kg per min of mexiletine intravenously followed by drip infusion of 15 µg/kg per min ; 7) pentisomide group, 5 mg/kg intravenously ; and 8) propafenone group, 2 mg/kg intravenously . Arterial blood pressure and electrocardiogram were monitored throughout the experiment .
chondrial function (the respiratory control index and the rate of oxygen consumption in state III) was measured polarographically . Fractionation of myocardial tissues was performed and the lysosomal enzyme (N-acetyl-/3-glucosaminidase and J3-glucuronidase) activities among fractions were measured .
No significant hemodynamic changes were observed compared with the control group except for those in the disopyramide and flecainide groups ; that is, decrease in heart rate without changes in blood pressure compared with the control group was observed .
All antiarrhythmic drugs effectively prevented the development of ventricular arrhythmias associated with ischemia . Two hours of coronary occlusion induced mitochondrial dysfunction and leakage of lysosomal enzymes . In contrast, each antiarrhythmic drug without exception lessened mitochondrial dysfunction and prevented the leakage of lysosomal enzymes concomitantly . These results indicate that class I antiarrhythmic drugs have cardioprotective effects on ischemic myocardium .
(J Am Coll Cardiol 1 8 ;14 21 -24) 21 is closely related to improvement of predisposing conditions for lethal arrhythmias . Beta-adrenergic blockers, class 11 and calcium channel antagonists, class IV antiarrhythmic drugs have cardioprotective effects on the ischemic heart (2-5) . Furthermore, recent studies (6) revealed that amiodarone, a class III antiarrhythmic drug, protects myocardial mitochondria against ischemia . In addition, it is reported (7, 8) that cardioprotective drugs, which are not classified as class I to IV antiarrhythmic drugs, showed an antiarrhythmic effect on the ischemic heart . Therefore, the relation between antiarrhythmic effect and cardioprotective effect has attracted much interest . Nevertheless, little information is available concerning the biochemical effects of class I antiarrhythmic drugs, the most widely used antiarrhythmic agents, on the ischemic heart ( ) .
In this study, we estimated the cardioprotective effects of various class I antiarrhythmic drugs on the ischemic heart by measuring changes in mitochondrial function and leakage of lysosomal enzymes as biochemical markers in the ischemic heart .
Methods
Animal preparation . Sixty-one adult mongrel dogs of either gender, weighing 7 to 12 kg, were anesthetized with sodium pentobarbital (50 mg/kg body weight) intraperitoneally . The dogs were intubated and ventilated with a Harvard type respirator (Igarashi Ika Kogyo) . Lead II of the electrocardiogram (ECG) was monitored continuously throughout the experiment by a VC-640G oscillographic recorder (Nihon Kohden) and recorded simultaneously by an ICR-7200 ambulatory ECG recorder (Nihon Kohden) . Catheters were placed in the right femoral artery and vein for monitoring aortic blood pressure (AD-600, Nihon Kohden) and for administration of drugs and adequate hydration, respectively . A left thoracotomy was performed in the fourth or fifth intercostal space, and the heart was suspended in a pericardial cradle . The left anterior descending coronary artery immediately distal to the first diagonal branch was dissected free and a silk suture was placed around the coronary artery for acute occlusion . Two hour occlusion was performed by ligating the vessel . The experiments performed conform to the Position of the American Heart Association on Research Animal Use adopted November 11, 1 84 by American Heart Association .
Experimental design . The 61 dogs were classified into eight groups . In the control group (n = 12) . physiologic saline solution was administered intravenously throughout the experiment . In the aprindine group (n = 7), 25 min before coronary occlusion, 3 mg/kg of aprindine hydrochloride dissolved in 25 ml of saline solution was administered intravenously for 10 min . In the disopyramide group (n = 7), 25 min before coronary occlusion, 2 mg/kg of disopyramide hydrochloride dissolved in 25 ml of saline solution was administered intravenously for 10 min . In the flecainide group (n = 7), 25 min before coronary occlusion, 2 mg/kg of flecainide acetate dissolved in 5 ml of distilled water was administered intravenously for 10 min followed by a constant infusion of 100 µg/kg per min dissolved in water (20 ml) with use of an infusion pump . In the lidocaine group (n = 7), 25 min before occlusion, 2 mg/kg of lidocaine hydrochloride dissolved in 5 ml of saline solution was administered intravenously for 10 min followed by a constant infusion of 100 µg/kg per min dissolved in saline solution (20 ml) with use of an infusion pump . In the mexiletine group (n = 7), 3 mg/kg of mexiletine hydrochloride dissolved in 5 ml of saline solution was administered intravenously for 10 min followed by a constant infusion of 15 µg/kg per min dissolved in saline solution (20 ml) with use of an infusion pump . In the pentisomide group (n = 7), 25 min before coronary occlusion, 5 mg/kg of pentisomide dissolved in 25 ml of water was administered intravenously for 10 min . In the propafenone group (n = 7), 25 min before coronary occlusion, 2 mg/kg of propafenone dissolved in 25 ml of water was administered intravenously for 10 min .
Hemodynamic measurements . Arterial blood pressure and heart rate were monitored throughout the experiment as described in the animal preparation section . To compare heart rate easily, delta heart rate was used ; this was defined as the difference between heart rate at preinjection (physiologic saline solution or drugs) and that during the period observed .
Analysis of arrhythmias . With the ambulatory ECG monitor, the number of premature ventricular beats during a 2 h period of occlusion was recorded and analyzed by an autoanalyzer (DMC-3110, Nihon Kohden) . To express the severity of arrhythmias, the total number of ventricular premature beats, the arrhythmia ratio (defined as the number of ventricular premature beats divided by the total heartbeats) and the total duration time of ventricular tachycardia were used . Ventricular tachycardia was defined as more than three successive ventricular premature beats .
Measurement of mitochondrial function . Two hours after occlusion of the left anterior descending coronary artery, to distinguish the ischemic area from the nonischemic area, Evans blue dye was infused through the femoral vein . Heart mitochondria from the nonischemic area and the ischemic area in each group were prepared by differential centrifugation according to the method of Hatefi et al . (10) . The rate of oxygen consumption in state III and the respiratory control index were measured . Oxygen consumption in mitochondria was measured polarographically with an oxygen electrode (UC-12, Central Kagaku) and a closed cell as described previously (11) . The incubation medium contained 0 .3 M mannitol, 10 mM potassium chloride, 10 mM potassium phosphate, 2 .5 mM magnesium chloride and 0 .25 mM ethylenediaminetetraacetic acid, pH 7 .4 , in a total of 0 .7 ml . Respiration was initiated by addition of 0 .03 ml of mitochondria) suspension (10 mg protein/ml), and then 0 .2 M succinic acid (0 .03 ml) as substrate and 10 mM adenosine diphosphate (0 .03 ml) were subsequently added . The rate of oxygen consumption in state III was calculated from mitochondrial oxygen consumption in number of atoms of oxygen consumed per milligram of mitochondrial protein per minute during state III respiration . The respiratory control index was taken as the ratio between the rate of oxygen consumption before and after the addition of adenosine diphosphate .
Measurement of lysosomal enzyme activities . According to the methods of Ruth et al . (12) and Kennett and Weglicki (13) , the endocardial tissue from the nonischemic area and the ischemic area in each group was immersed in the extraction medium (0 .25 M sucrose, 0 .6 M potassium chloride, I mM adenosine triphosphate, i mM ethylenediaminetetraacetic acid and 1 mM magnesium chloride, buffered with imidazole at pH 7 .2) . The tissue was then homogenized with a Teflon pestle tissue grinder . Pellets were obtained by were considered statistically significant . All data in this study were expressed as mean ± SD . 
Results
Of the 61 dogs that underwent coronary artery occlusion, 5 of the 12 dogs in the control group died of ventricular fibrillation and were excluded from the subsequent analysis .
No dogs died in the drug-treated groups . Data for the remaining 56 dogs form the basis of the report .
Hemodynamics (Table 1 ) . In the disopyramide and flecainide groups, decreases in heart rate were observed without significant changes in arterial blood pressure . However, neither arterial blood pressure nor delta heart rate in the other drug-treated groups changed significantly from values in the control group throughout the experiment .
Arrhythmias (Table 2) . Administration of antiarrhythmic drugs reduced significantly the total number of premature ventricular beats compared with those of the control group .
Similar tendencies were observed in the arrhythmia ratio and the total duration of ventricular tachycardia .
Mitochondrial function ( the respiratory control index was observed in the ischemic area . In all drug-treated groups, significant improvement of the rate of oxygen consumption in state III in the ischemic areas was observed compared with that of the control group, although these values were lower than those from the respective nonischemic areas . Similar results were observed in the respiratory control index . Lysosomal enzyme activities (Table 4 ) . In the ischemic area, the activity of N-acetyl-/3-glucosaminidase was significantly decreased in the post ,000 g to 140,000 g particulate fractions ; conversely, the activity of N-acetyl-/3-glucosaminidase was increased significantly in the supernatant fraction in the ischemic area . Similar tendencies were observed in the activity of /3-glucuronidase in the control group . In all antiarrhythmic drug-treated groups, decreases in the activity of N-acetyl-/3-glucosaminidase in the ,000 g, 20,000 g and 140,000 g fractions and increases in the activity of Nacetyl-/3-glucosaminidase in the supernatant fraction in the ischemic area were not observed . Similar tendencies were observed in the activity of /3-glucuronidase ; that is, admin- Table 3 . Indexes of Mitochondrial Function in All Drug Groups istration of antiarrhythmic drugs prevented lysosomal enzyme leakage induced by 2 h coronary occlusion .
Discussion
Mitochondria and lysosomes cardioprotective effects of class I antiarrhythmic drugs . Myocardial ischemia produces contractile, biochemical and structural abnormalities . Because ischemia causes a decrease in the supply of oxygen and nutrition, there is a consequent marked decrease in energy production in mitochondria with cessation of coronary artery flow . Moreover, because mitochondria exclusively produce high energy phosphate, particularly adenosine triphosphate, maintenance of mitochondrial function is of primary importance for maintaining cellular integrity . Therefore, persistent mitochondrial dysfunction is suggested to lead directly to cellular death (16) . Leakage of various lysosomal hydrolytic enzymes might play an important role in the irreversible changes in the ischemic myocardium (17) . Hence, estimation of mitochondrial function and leakage of lysosomal enzymes might be useful for assessing myocardial injury after coronary occlusion .
In the present study, mitochondrial function in the ischemic area of the control group was decreased significantly compared with that in the nonischemic area . Leakage of lysosomal enzymes was also observed in ischemic myocardium . Administration of each class I antiarrhythmic drug lessened mitochondrial dysfunction induced by ischemia and prevented leakage of lysosomal enzymes . The myocardial injury associated with acute infarction is ascribed to both ischemia itself and hemodynamic changes . The risk area associated with left anterior descending artery occlusion was estimated to be 30% to 40% (18, 1 ) . Experimental ligation of the left anterior descending coronary artery produces a moderate-sized infarct without severe hemodynamic changes, as observed in the present study . No drug significantly changed either systolic or diastolic pressure . No *n atoms/mg protein/min '1p < 0.01 vs . nonischemic area of the corresponding group tp < 0 .01 versus ischemic area of the control group . All values are mean ± SD. significant changes in delta heart rate except at 0, 30 and 60 min of coronary occlusion in the disopyramide group and at 0 and 30 min in the flecainide group were observed . In addition, we estimated mitochondrial function and lysosomal enzyme activities in ischemic myocardium, which was defined as the area not stained by Evans blue dye . Hence, the beneficial effects of the class I antiarrhythmic drugs used here might be based on the direct cardioprotective effects and not on the improvement in hemodynamic status . Efficacy of class I antiarrhythmic drugs in ventricular arrhythmias . Ventricular arrhythmias associated with myocardial ischemia may be a severe hazard that cardiologists have to confront in the clinical setting, and many antiarrhythmic agents have been developed . Vaughan Williams (20) classified these antiarrhythmic agents into four categories mainly on the basis of their electrophysiologic properties . Class I type antiarrhythmic agents were classified into three subgroups (21) based on their effect on action potential duration . Disopyramide belongs to class la, aprindine, lidocaine, mexiletine and pentisomide to class Ib, and flecainide and propafenone to class Ic . Disopyramide is reported to be effective for treatment of ventricular arrhythmias in patients with suspected acute myocardial infarction (22) . Aprindine is also effective in reducing ventricular arrhythmias after acute infarction (23) . Lidocaine remains the standard antiarrhythmic drug for ventricular arrhythmias during the coronary care phase of acute myocardial infarction . Koster and Dunning (24) reported that lidocaine, administered by paramedics to patients with suspected myocardial infarction, reduced the occurrence of ventricular fibrillation . Mexiletine is a congener of lidocaine with similar chemical and electrophysiologic properties . Clinical study confirmed the efficacy of mexiletine for ventricular arrhythmias (25) . Pentisomide is a well tolerated and effective compound of potential value for treatment of ventricular arrhythmias (26) . Flecainide is also a useful compound in patients with lifethreatening arrhythmias (27) . Propafenone is a unique antiarrhythmic drug and its efficacy in patients with ventricular arrhythmias has been confirmed clinically (28) .
Antiarrhythmic action and cardioprotective effect. Regardless of the subclassification of class I antiarrhythmic drugs, every drug used here showed a cardioprotective effect as well as an antiarrhythmic effect . It is well known that intraaortic balloon pumping suppresses ventricular arrhythmias associated with severe ischemia, and these favorable effects might be ascribed to the improvement in the hemodynamic state (2 ) . It is also reported that the severity of ventricular arrhythmias observed in ischemia depends on the extent of necrosis (30 contribute to their antiarrhythmic effect . The major action of class I antiarrhythmic drugs is based on the inhibition of the sodium channel (31) . Jennings et al . (32) reported that sodium and water content increased in ischemic myocardium . From our results, sodium influx might play an important role in the development of ischemia-induced myocardial damage . It is well known that the calcium ion plays an important role in both the genesis of myocardial injury and the development of arrhythmias . It could not be ruled out that class I antiarrhythmic drugs might alter the regulation of intracellular calcium ion such as the release of calcium ion from sarcoplasmic reticulum, although further investigation is necessary to clarify the details . We should emphasize that every class I drug used here, although differing in subgroup classification, protects myocardium against ischemia, and that administration of class I drugs might favorably alter metabolic changes in patients with acute ischemia because the doses used in the present study are similar to those used clinically .
